Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Clinical trial NCT07175428 · RECRUITING
Trial details
- NCT number
- NCT07175428
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-20
- Primary completion
- 2027-02-09
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.